Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 16,253 | 14,078 | 11,415 | 10,258 | 7,479 |
| Operating Income | -16,253 | -14,078 | -11,415 | -10,258 | -7,479 |
| Other Income | 319 | 14 | -11 | -47 | 0 |
| Pre-tax Income | -15,934 | -14,064 | -11,426 | -10,305 | -7,479 |
| Net Income Continuous | -15,934 | -14,064 | -11,426 | -10,305 | -7,479 |
| Net Income | $-15,934 | $-14,064 | $-11,426 | $-10,305 | $-7,479 |
| EPS Basic Total Ops | -0.47 | -0.41 | -0.42 | -0.39 | -0.28 |
| EPS Basic Continuous Ops | -0.47 | -0.42 | -0.42 | -0.39 | -0.28 |
| EPS Diluted Total Ops | -0.47 | -0.41 | -0.42 | -0.39 | -0.28 |
| EPS Diluted Continuous Ops | -0.47 | -0.42 | -0.42 | -0.39 | -0.28 |
| EBITDA(a) | $-16,234 | $-14,064 | $-11,406 | $-10,258 | $-7,479 |